Analyst Recommendations

Citigroup analyst issues OUTPERFORM recommendation for SKWD on October 30, 2025 10:25AM ET. The previous analyst recommendation was Outperform.SKWD was trading at $45.01 at issue of the analyst...

October 30, 2025   SKWD -0.83%

Canaccord Genuity analyst issues BUY recommendation for TMDX on October 30, 2025 10:27AM ET. The previous analyst recommendation was Buy.TMDX was trading at $134.32 at issue of the...

October 30, 2025   TMDX -5.84%

Canaccord Genuity analyst issues BUY recommendation for WAY on October 30, 2025 10:27AM ET. The previous analyst recommendation was Buy.WAY was trading at $39.62 at issue of the...

October 30, 2025   WAY 1.52%

Barclays analyst issues OVERWEIGHT recommendation for GH on October 30, 2025 10:27AM ET. The previous analyst recommendation was Overweight.GH was trading at $72.27 at issue of the analyst...

October 30, 2025   GH 4.40%

Wells Fargo analyst issues CAUTIOUS recommendation for BIO on October 30, 2025 10:28AM ET. The previous analyst recommendation was Cautious.BIO was trading at $319.47 at issue of the...

October 30, 2025   BIO -0.86%

Barclays analyst issues OVERWEIGHT recommendation for IONS on October 30, 2025 10:27AM ET. The previous analyst recommendation was Overweight.IONS was trading at $71.88 at issue of the analyst...

October 30, 2025   IONS 0.74%

Canaccord Genuity analyst issues HOLD recommendation for REYN on October 30, 2025 10:27AM ET. The previous analyst recommendation was Hold.REYN was trading at $24.95 at issue of the...

October 30, 2025   REYN -0.21%

Barclays analyst issues OVERWEIGHT recommendation for KLAC on October 30, 2025 10:28AM ET. The previous analyst recommendation was Overweight.KLAC was trading at $1235.28 at issue of the analyst...

October 30, 2025   KLAC -3.00%

Wells Fargo analyst issues REDUCE recommendation for OKE on October 30, 2025 10:27AM ET. The previous analyst recommendation was Reduce.OKE was trading at $67.2 at issue of the...

October 30, 2025   OKE 0.50%

Barclays analyst issues UNDERWEIGHT recommendation for NOV on October 30, 2025 10:38AM ET. The previous analyst recommendation was Underweight.NOV was trading at $15.31 at issue of the analyst...

October 30, 2025   NOV -4.01%